FSD Pharma Announces New Leadership Appointment and Board Change
Dr. Sara May has been appointed as President of FV Pharma Vladimir Klacar departs from FSD Pharma's Board of Directors TORONTO, March 13, 2019 /CNW/ - FSD Pharma Inc. (CSE:HUGE) (OTCQB:FSDDF) (FRA: 0K9) ("FSD" or the "Company"), a licensed producer ... [Read]
FSD Pharma Enters into Five Year Supply and Loan Agreement with Canntab Therapeutics and World Class Extractions on Organic Hemp Deal
- FSD enters into agreement for right/ option to purchase up to CAD$ 5 million of hemp crop for 5 years commencing in 2019 - TORONTO, Feb. 28, 2019 /CNW/ - FSD Pharma Inc. (CSE:HUGE) (OTCQB:FSDDF) (FRA: 0K9) ("FSD" ... [Read]
FSD Pharma Receives Standard Processing License
TORONTO, Feb. 19, 2019 /CNW/ - FSD Pharma Inc. ("FSD Pharma" or the "Company") (CSE:HUGE) (OTC:FSDDF) (FRA: 0K9) announced today that its wholly-owned subsidiary, FV Pharma Inc. ("FV Pharma"), a licensed cannabis producer under the Cannabis Act, has received its Standard ... [Read]
FSD Pharma Provides Update on Operations, Strategy and Leadership
TORONTO, Feb. 14, 2019 /CNW/ - FSD Pharma Inc. (CSE:HUGE) (OTCQB:FSDDF) (FRA: 0K9) ("FSD"), a licensed producer under the Cannabis Act, today provided a corporate update on operations, strategy and leadership changes. Management Changes On February 6, 2019, the Company announced ... [Read]
FSD Pharma Enters into Supply Agreement with Canntab Therapeutics and World Class Extractions on Organic Hemp Deal
- FSD enters into 3-way supply agreement to purchase up to 1,000 kg of 2018 hemp crop - TORONTO, Feb. 12, 2019 /CNW/ - FSD Pharma Inc. (CSE:HUGE) (OTCQB:FSDDF) (FRA: 0K9) ("FSD"), a licensed producer under the Cannabis ... [Read]
FSD Pharma responds to and corrects misleading Auxly claims
TORONTO, Feb. 8, 2019 /CNW/ - FSD Pharma Inc.(CSE:HUGE) (OTCQB:FSDDF) (FRA: 0K9) a licensed producer under the Cannabis Act, responded today to a press release by its former partner, Auxly Cannabis Group Inc. ("Auxly") to correct misleading claims. FSD Pharma strongly denies that it caused ... [Read]
FSD Pharma Signs Collaboration and Profit-Sharing Agreement with Pharmastrip for Production and Delivery of Organic Medical Cannabis Infused in Oral Thin Film Strips
- FSD receives exclusive, perpetual license to manufacture and sell oral film strips in Canada - TORONTO, Feb. 7, 2019 /CNW/ - FSD Pharma Inc. (CSE:HUGE) (OTCQB:FSDDF) (FRA: 0K9) ("FSD" or the "Company), a licensed producer under the Cannabis Act, announced ... [Read]
FSD Pharma Announces Signing of LOI with Solarvest to Develop and Test Pharma-Grade Cannabinoids out of Algae
PHARMA GRADE PROCESS COULD REDUCE THE PRODUCTION TIME FOR TARGETED CANNABINOID MOLECULE(S) CSE:HUGE OTC:FSDDF FRA: 0K9 TORONTO, Feb. 5, 2019 /CNW/ - FSD Pharma Inc. (CSE:HUGE) (OTC: FSDDF) ("FSD Pharma") and Solarvest BioEnergy Inc. (TSX-V: SVS) ("Solarvest") (collectively, the "Parties"), a technology company ... [Read]
FSD Pharma Congratulates Cannara Biotech for Its Listing and Commencement of Trading on the CSE
CSE: HUGE OTCQB: FSDDF FRA: 0K9 TORONTO, Jan. 14, 2019 /CNW/ - FSD Pharma Inc. ("FSD" or the "Company") (CSE:HUGE) (OTCQB:FSDDF) (FRA: 0K9) would like to congratulate Cannara Biotech Inc. ("Cannara") for its listing approval and commencement ... [Read]
FSD Pharma Announces Strategic Investment in Huge Shops
- Huge Shops forms alliance with Coffee Time's parent company Chairman's Brands to establish retail distribution network - TORONTO, Dec. 20, 2018 /CNW/ - FSD Pharma Inc. ("FSD Pharma" or "FSD") (CSE:HUGE) (OTCQB:FSDDF) (FRA: 0K9) has completed a strategic ... [Read]